235 related articles for article (PubMed ID: 22070434)
1. Toll-like receptors and diabetes: a therapeutic perspective.
Dasu MR; Ramirez S; Isseroff RR
Clin Sci (Lond); 2012 Mar; 122(5):203-14. PubMed ID: 22070434
[TBL] [Abstract][Full Text] [Related]
2. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress.
Pahwa R; Jialal I
Metab Syndr Relat Disord; 2016 Jun; 14(5):239-41. PubMed ID: 27105077
[TBL] [Abstract][Full Text] [Related]
4. Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs).
Franchini M; Zini E; Osto M; Jablonski K; Kaufmann K; Lutz TA; Reusch CE; Ackermann M
Vet Immunol Immunopathol; 2010 Nov; 138(1-2):70-8. PubMed ID: 20674989
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors and diabetes.
Wong FS; Wen L
Ann N Y Acad Sci; 2008 Dec; 1150():123-32. PubMed ID: 19120280
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors and innate immunity.
Kumar H; Kawai T; Akira S
Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
[TBL] [Abstract][Full Text] [Related]
7. [Expression and function of toll-like receptors in B lymphocytes].
Liu HZ; Yang HZ; Hu ZW
Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):114-8. PubMed ID: 18664173
[TBL] [Abstract][Full Text] [Related]
8. Role of Toll-like receptors in infection and immunity: clinical implications.
Cristofaro P; Opal SM
Drugs; 2006; 66(1):15-29. PubMed ID: 16398566
[TBL] [Abstract][Full Text] [Related]
9. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
Cole JE; Mitra AT; Monaco C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
[TBL] [Abstract][Full Text] [Related]
10. Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients.
Dandona P; Ghanim H; Green K; Sia CL; Abuaysheh S; Kuhadiya N; Batra M; Dhindsa S; Chaudhuri A
Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E810-8. PubMed ID: 23403945
[TBL] [Abstract][Full Text] [Related]
11. [Innate immunity: cutaneous expression of Toll-like receptors].
Musette P; Auquit Auckbur I; Begon E
Med Sci (Paris); 2006 Feb; 22(2):149-52. PubMed ID: 16457754
[TBL] [Abstract][Full Text] [Related]
12. Modulation of toll-like receptors by insulin.
Tilich M; Arora RR
Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
[TBL] [Abstract][Full Text] [Related]
13. The role of TLRs in neutrophil activation.
Prince LR; Whyte MK; Sabroe I; Parker LC
Curr Opin Pharmacol; 2011 Aug; 11(4):397-403. PubMed ID: 21741310
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors and diabetes complications: recent advances.
Rosa Ramirez S; Ravi Krishna Dasu M
Curr Diabetes Rev; 2012 Nov; 8(6):480-8. PubMed ID: 22934553
[TBL] [Abstract][Full Text] [Related]
15. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
[TBL] [Abstract][Full Text] [Related]
16. The innate immune system, toll-like receptors and dermal wound healing: A review.
Portou MJ; Baker D; Abraham D; Tsui J
Vascul Pharmacol; 2015 Aug; 71():31-6. PubMed ID: 25869514
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Toll-like receptor signaling pathways in innate immune responses.
Qian C; Cao X
Ann N Y Acad Sci; 2013 Apr; 1283():67-74. PubMed ID: 23163321
[TBL] [Abstract][Full Text] [Related]
18. Toll Like Receptors in systemic sclerosis: An emerging target.
O'Reilly S
Immunol Lett; 2018 Mar; 195():2-8. PubMed ID: 28888416
[TBL] [Abstract][Full Text] [Related]
19. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.
Nogueira-Machado JA; Volpe CM; Veloso CA; Chaves MM
Expert Opin Ther Targets; 2011 Aug; 15(8):1023-35. PubMed ID: 21585289
[TBL] [Abstract][Full Text] [Related]
20. The production of reactive oxygen species in TLR-stimulated granulocytes is not enhanced by hyperglycemia in diabetes.
Fagundes-Netto FS; Anjos PM; Volpe CM; Nogueira-Machado JA
Int Immunopharmacol; 2013 Nov; 17(3):924-9. PubMed ID: 24121038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
